Abiraterone Acetate
Back to searchMolecule Structure
Scientific Name
Abiraterone Acetate
Brand Name(s)
Yonsa, Zytiga
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Msn Laboratories Private Ltd, Wockhardt Bio Ag, Apotex Inc, Janssen Biotech Inc, Sun Pharmaceutical Industries Ltd, Novugen Oncology Sdn Bhd, Dr Reddys Laboratories Ltd, Glenmark Pharmaceuticals Sa, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 17A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL3522 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL93715 | ||
PubChem: Thomson Pharma | 14780798 | 15425637 | |
PubChem | 9821849 | ||
Nikkaji | J617.458B | ||
BindingDB | 50407398 | ||
EPA CompTox Dashboard | DTXSID3049043 | ||
DrugCentral | 4176 | ||
Brenda | 108342 | 15181 | |
ChemicalBook | CB81396153 | ||
Guide to Pharmacology | 9288 | ||
rxnorm | ABIRATERONE ACETATE | YONSA | ZYTIGA |
PubChem: Drugs of the Future | 92309396 | ||
ChEBI | 68639 | ||
ZINC | ZINC000003809191 |